jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

April. 10, 2026

July. 16, 2026

jRCT2031260035

A phase IIb, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Ranging Study of M610101 in Patients with Nonsegmental Vitiligo

A phase IIb, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Ranging Study of M610101 in Patients with Nonsegmental Vitiligo

Nishiura Tomoyuki

Maruho Co.,Ltd. Kyoto R&D Center

93 Chudoji Awatacho, Shimogyo-ku, Kyoto

+81-75-325-3279

ctinfo@mii.maruho.co.jp

- Clinical Trials Information

Maruho Co.,Ltd. Kyoto R&D Center

93 Chudoji Awatacho, Shimogyo-ku, Kyoto

+81-75-325-3279

ctinfo@mii.maruho.co.jp

Recruiting

April. 10, 2026

May. 13, 2026
120

Interventional

randomized controlled trial

double blind

placebo control

parallel assignment

treatment purpose

(1) Participants aged 12 years and older with a clinical diagnosis of non-segmental vitiligo
(2) >=0.5 facial-VASI(F-VASI) score
(3) >=3 total body-VASI(F-VASI) score

(1) Patients complicated with diseases considered inappropriate for participation in clinical trials such as serious cardiac / hepatic / renal / pulmonary / hematologic disease
(2) Patients with non-segmental vitiligo or skin pigmentation disorders that may affect the evaluation or safety of the subject

12age old over
No limit

Both

Non-segmental vitiligo

Apply 2 times a day.

Proportion of participants achieving F-VASI75 at Week 24.

Maruho Co.,Ltd.
Medical corporation Shintoukai Yokohamaminoru Clinic IRB
1-13-8, Bessho Minami-ku Yokohama-shi, Kanagawa

+81-42-648-5551

yminoru-irb@eps.co.jp
Not approval

April. 16, 2026

No

none

History of Changes

No Publication date
3 July. 16, 2026 (this page) Changes
2 June. 03, 2026 Detail Changes
1 April. 10, 2026 Detail